Multiple Sclerosis Journal - Experimental, Translational and Clinical
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherSAGE PUBLICATIONS INC
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2000
- Publication Time15
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2015
- Publisher URL
- Website URL
- Other charges
- Plagiarism
- Publication Time15
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- License typeCC BY, CC BY-NC
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 0% |
| 4-6 | 44% |
| 7-9 | 38% |
| >9 | 18% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Multiple Sclerosis Journal - Experimental, Translational and Clinical been publishing? 
The Multiple Sclerosis Journal - Experimental, Translational and Clinical has been publishing since 2015 till date.
How frequently is the Multiple Sclerosis Journal - Experimental, Translational and Clinical published?
Multiple Sclerosis Journal - Experimental, Translational and Clinical is published Continuous publication.
Who is the publisher of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
The publisher of Multiple Sclerosis Journal - Experimental, Translational and Clinical is SAGE PUBLICATIONS INC.
How can I view the journal metrics of Multiple Sclerosis Journal - Experimental, Translational and Clinical on editage?
For the Multiple Sclerosis Journal - Experimental, Translational and Clinical metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
The eISSN number is 2055-2173 and pISSN number is 2055-2173 for Multiple Sclerosis Journal - Experimental, Translational and Clinical.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Multiple sclerosis, Progressive multiple sclerosis, Alemtuzumab, Symbol digit modalities test, Quality of life, Decisional conflict, Remote administration, Fingolimod, Exercise, Clinically isolated syndrome, Expanded Disability Status Scale, Physical function, Natalizumab, Gene expression, Cognitive screening, Ocrelizumab, Paced Auditory Serial Addition Test, Teriflunomide, Magnetic resonance imaging, Systematic review.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.